Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDBeta Bionics Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 3 | -$0.48 | -$0.40 | -$0.46 |
| Q2 2026 | 4 | -$0.61 | -$0.37 | -$0.46 |
| Q3 2026 | 1 | -$0.48 | -$0.39 | -$0.44 |
| Q4 2026 | 1 | -$0.50 | -$0.41 | -$0.45 |
| Q1 2027 | 1 | -$0.46 | -$0.37 | -$0.41 |
| Q2 2027 | 1 | -$0.45 | -$0.37 | -$0.41 |
| Q3 2027 | 1 | -$0.47 | -$0.38 | -$0.43 |
| Q4 2027 | 1 | -$0.45 | -$0.37 | -$0.41 |
| Q1 2028 | 2 | $0.00 | $0.00 | $0.00 |
| Q2 2028 | 2 | $0.00 | $0.00 | $0.00 |
| Q3 2028 | 2 | $0.00 | $0.00 | $0.00 |
| Q4 2028 | 2 | $0.00 | $0.00 | $0.00 |
Beta Bionics Inc. Earnings Date And Information
Beta Bionics Inc. last posted its earnings results on Tuesday, February 17th, 2026. The company reported $-0.3 earnings per share for the quarter, topping analysts' consensus estimates of $-0.42 by $0.12. The company had revenue of 32.12 M for the quarter and had revenue of 100.25 M for the year. Beta Bionics Inc. has generated $-2 earnings per share over the last year ($-1.81 diluted earnings per share) and currently has a price-to-earnings ratio of -7.54. Beta Bionics Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Beta Bionics Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/17/2026 | Q4 2025 | -$0.42 | -$0.16 | 0.26 | N/A | $32.12 M |
| 10/28/2025 | Q3 2025 | -$0.45 | -$0.33 | 0.12 | $23.97 M | $27.25 M |
| 07/29/2025 | Q2 2025 | -$0.51 | -$0.39 | 0.12 | $19.69 M | $23.24 M |
| 05/06/2025 | Q1 2025 | -$0.51 | -$0.93 | -0.42 | N/A | $17.64 M |
| 03/25/2025 | Q4 2024 | -$0.42 | -$0.42 | 0 | N/A | $20.44 M |
| 09/30/2024 | Q3 2024 | N/A | -$1.55 | N/A | N/A | $16.71 M |
| 06/29/2024 | Q2 2024 | N/A | -$0.33 | N/A | N/A | $15.05 M |
| 03/31/2024 | Q1 2024 | N/A | -$0.41 | N/A | N/A | $12.93 M |
| 12/31/2023 | Q4 2023 | N/A | -$3.13 | N/A | N/A | $8.35 M |
| 09/30/2023 | Q3 2023 | N/A | -$1.71 | N/A | N/A | $3.09 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Beta Bionics Inc. Earnings: FAQ's
In the previous quarter, Beta Bionics Inc. (:BBNX) reported $-0.3 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.42 by $0.12.
The conference call for Beta Bionics Inc.'s latest earnings report can be listened to online.
The conference call transcript for Beta Bionics Inc.'s latest earnings report can be read online.
Beta Bionics Inc. (:BBNX) has a recorded annual revenue of $100.25 M.
Beta Bionics Inc. (:BBNX) has a recorded net income of $-73,200,000.Beta Bionics Inc. has generated $-1.81 earnings per share over the last four quarters.
Beta Bionics Inc. (:BBNX) has a price-to-earnings ratio of -7.54 and price/earnings-to-growth ratio is -0.6.